Publications by authors named "Pedro C Rodriguez"

Claim this Profile
A
Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule.
Xitlally Popa, Beatriz García, Karla P Fuentes, Vivian Huerta, Karen Alvarez

Oncoimmunology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer.
Lizet Sanchez, Leacky Muchene, Patricia Lorenzo-Luaces, Carmen Viada, Pedro C Rodriguez

Semin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Patricia Hernández, Ernesto Moreno, Lazaro E Aira, Pedro C Rodríguez

Curr Drug Targets· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Pedro C Rodriguez, Xitllaly Popa, Odeth Martínez, Silvia Mendoza, Eduardo Santiesteban

Clin Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.
Tania Crombet Ramos, Pedro Camilo Rodríguez, Elia Neninger Vinageras, Beatriz Garcia Verdecia, Agustin Lage Davila

Expert Rev Vaccines· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.
Pedro C Rodriguez, Belinda Sanchez

Curr Top Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.
Pedro C Rodriguez, Roberto Torres-Moya, Gil Reyes, Claudino Molinero, Dinorah Prada

Results Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients.
Pedro C Rodriguez, Elia Neninger, Beatriz García, Xitlally Popa, Carmen Viada

J Immune Based Ther Vaccines· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy.
Pedro C Rodríguez, Gryssell Rodríguez, Gisela González, Agustín Lage

MEDICC Rev· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine.
Pedro C Rodriguez, Ileana Gonzalez, Adys Gonzalez, Janet Avellanet, Armando Lopez

Vaccine· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Does age have any bearing on the incidence of extrapulmonary tuberculosis?].
Antonio Burgos Teruel, Leandro Hueso Estornell, Pedro Cordero Rodríguez, Antonio Guerrero Espejo

Rev Esp Salud Publica· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effect of Mangifera indica L. polyphenols on human T lymphocytes against activation-induced cell death.
Patricia Hernandez, Pedro C Rodriguez, Rene Delgado, Henning Walczak

Pharmacol Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis